Abstract
We isolated and purified phenolic acids and flavonoids from the ethanolic extract of Salvia plebeia using silica gel and a Sephadex LH-20 column chromatography. Spectroscopy revealed the isolated compounds were caffeic acid, rosmarinic acid, hispidulin, luteolin, jaceosidin, nepitrin, homoplantaginin, 6-hydroxyluteolin 7-O-glucoside, 6-methoxynaringenin 7-O-glucoside, naasanone, and cosmosiin. Quantitative analyses, using high-performance liquid chromatography coupled with UV (HPLC-UV), revealed that the major flavonoid from S. plebeia was 6-hydroxyluteolin 7-O-glucoside (100.63 mg/g) and the most abundant phenolic acid was rosmarinic acid (47.73 mg/g). Furthermore, among four other Salvia species, S. officinalis contained the highest overall phenolic acid and flavonoid level but these were still lower than S. plebeia. These results can help assess the potential of phenolic acids and flavonoids as potent sources of pharmacological ingredients from different Salvia species extracts.
Keywords: Salvia plebeia, Open column chromatography, 6-hydroxyluteolin 7-O-glucoside, Rosmarinic acid, HPLC-UV analysis
Salvia plebeia; Open column chromatography; 6-hydroxyluteolin 7-O-glucoside; Rosmarinic acid; HPLC-UV analysis.
1. Introduction
Plants from traditional Chinese medicine (TCM) are important sources of natural products to develop new drugs and drug intermediates (Ren et al., 2014). Therefore, separation, isolation, characterization, and quantification of such bioactive compounds from plant source materials are vital. Salvia plebeia has been widely used in TCM as it contains diverse chemical components. It is a medically important plant of the genus Salvia that is commonly distributed throughout China, India, Japan, and Korea (Lee et al., 2018). Traditional prescriptions of this plant include treating nephritis, hepatitis, bronchitis, the common cold, flu, cough, and rheumatoid arthritis (Liang et al., 2020; Choi et al., 2015). Importantly, these traditional applications have been scientifically confirmed and validated. S. plebeia displayed strong antibacterial, antioxidant, anti-inflammatory, and antiviral effects according to literatures (Wang et al., 2018). Furthermore, recent studies on the plants’ biological activities indicated anti-atopic dermatitis, anti-asthma, anti-cancer, anti-obesity, anti-oxidant, and anti-influenza effects (Kil et al., 2020; Liang et al., 2020).
Approximately 75 phenolic acids and 50 flavonoids have been isolated from 23 and 51 Salvia species, respectively (Lu and Foo, 2002). These phytochemicals are considered major bioactive components of S. plebeia. Aside from phenolic acids and flavonoids, diverse classes of compounds such as diterpenoids, phenylpropanoids, sesquiterpenoids, and phytosterols have also been identified (Liang et al., 2020). Considerable efforts have been expended to the development of functional food ingredients from S. plebeia as its biological effects are mostly attributed to its high contents of flavonoids. Nepetin, hispidulin, apigenin, luteolin, and their glycosides are the major flavonoid constituents present in S. plebeia. These types of flavones are major phytochemicals responsible for the potent biological activity of the plant (Lee et al., 2018). Therefore, studies that isolate and quantify these marker compounds are warranted to help characterize their biological potency.
This study isolated compounds from the ethanol (EtOH) extract of S. plebeia (SPE) using open column chromatography. Structure elucidation using nuclear magnetic resonance (NMR) and mass spectroscopy (MS) was performed to identify the compounds. Quantitative analyses of SPE, S. plebeia methanol (MeOH) extract (SPM), and S. plebeia water (DW) extract (SPW), with MeOH extracts from three different Salvia species, S. japonica (SJM), S. splendens (SSM), and S. officinalis (SOM) were also conducted using high-performance liquid chromatography coupled with UV (HPLC-UV). By further isolating and quantifying compounds from S. plebeia and performing a chemical profiling of compounds from different Salvia species, we assessed their potential as sources of pharmacological ingredients.
2. Materials and methods
2.1. Plant materials
The aerial parts of S. plebeia were collected with support from Gimpo Agricultural Extension Center (2019), Gimpo, Korea. A voucher specimen was deposited at the Department of Plant Science and Technology Herbarium, Chung-Ang University, Korea. SJM, SSM, and SOM were acquired from Korea Research Institute of Bioscience & Biotechnology, Daejeon, Korea.
2.2. Reagents and instruments
The solvents MeOH, EtOH, n-butanol (n-BuOH), chloroform (CHCl3), ethyl acetate (EtOAc), and n-hexane were purchased from Samchun Pure Chemicals Co., Pyeongtaek, Korea. HPLC-grade solvents such as acetonitrile (ACN), acetic acid, MeOH, and DW were obtained from J.T. Baker Chemicals (Avantor, Radnor, PA, USA). For open column chromatography, a column was packed with silica gel (60–200 μm, Merck Co., Darmstadt, Germany) and Sephadex LH-20 (Sigma-Aldrich, St. Louis, MO, USA). Thin-layer chromatography (TLC) analyses were conducted on a glass pre-coated with silica gel 60 (Merck Co., Darmstadt, Germany). NMR spectra were recorded on an AVANCE NMR spectrometer (Rheinstetten, Germany) operating at 500 MHz for 1H-NMR and 125 MHz for 13C-NMR. MS spectra were recorded using a JEOL-MS spectrometer (Tokyo, Japan). Quantitative analyses were conducted using an HPLC Agilent 1260 Infinity II LC system (Santa Clara, CA, USA) equipped with a pump, auto-sampler, and UV detector. All standards were isolated from S. plebeia (Figure 1).
Figure 1.
Chemical structures of phenolic acids and flavonoids from SPE. caffeic acid (1), rosmarinic acid (2), hispidulin (3), luteolin (4), jaceosidin (5), nepitrin (6), homoplantaginin (7), 6-hydroxyluteolin 7-O-glucoside (8), 6-methoxynaringenin 7-O-glucoside (9), naasanone (10), and cosmosiin (11).
2.3. Extraction, fractionation, and isolation
Dried aerial parts of S. plebeia (1.6 kg) were ground to obtain a powder. The powder was then extracted under reflux in 95% ethanol at 80 °C for 3 h and repeated three times using a soxhlet extractor. The resulting extract solution was filtered and concentrated using a rotary evaporator to obtain crude EtOH extract (SPE, 360 g). SPE (340 g) was suspended in DW and sequentially partitioned with equal volumes of n-hexane, CHCl3, EtOAc and n-BuOH to obtain n-hexane (21 g), CHCl3 (5 g), EtOAc (17 g), and n-BuOH fractions (22 g), respectively. The EtOAc fraction (10.0 g) of SPE was subjected to silica gel column chromatography and was eluted with a step-wise gradient system of CHCl3:MeOH (100:0 to 0:100 v/v) and collected to obtain fractions. The fractions were analyzed using TLC and combined which resulted further into six sub-fractions. Sub-fraction 1 was subjected to purification using Sephadex LH-20 column and was eluted with a step-wise gradient of H2O:MeOH (5:1 to 1:5 v/v) to obtain the compound 3. Sub-fraction 3 was also purified in Sephadex LH-20 column using the previously described method to obtain compounds 4 and 5. Compound 9 was isolated by purifying the vials in sub-fraction 4 using the MeOH recrystallization method. Compound 1 was obtained from the first 5 vials of sub-fraction 5. Vials 20–30 were subjected to MeOH recrystallization to obtain compound 10. The remaining vials were re-chromatographed in an Sephadex LH-20 column eluted with H2O:MeOH which resulted in obtaining crystals. The crystals were then analyzed using TLC and divided into 2 sub-fractions (5a and 5b). Sub-fraction 5a yielded compounds 2 and 11 was obtained from sub-fraction 5b. Compound 6 was obtained from sub-fraction 6 by MeOH recrystallization. The n-BuOH fraction (12.0 g) of SPE was chromatographed on a silica gel column and was eluted with a gradient system of CHCl3:MeOH (100:0 to 0:100 v/v) in a step-wise manner to afford 4 sub-fractions. Sub-fraction 2 was subjected to MeOH recrystallization to obtain compound 7. Sub-fraction 4 was re-chromatographed in the Sephadex LH-20 column eluted with a gradient system of increasing MeOH in H2O to afford compound 8.
Compound 1: White powder; C9H8O4; EI-MS: m/z 180 [M]+ (100), 163 (39.0), 134 (49.0), 89 (25.0), 77 (13.0); 1H-NMR (500 MHz, DMSO-d6): δ 7.40 (1H, d, J = 15.5 Hz, H-7), 7.01 (1H, d, J = 2.0 Hz, H-2), 6.95 (1H, dd, J = 8.5, 2.0 Hz, H-6), 6.75 (1H, d, J = 8.0 Hz, H-5), 6.16 (1H, d, J = 16.0 Hz, H-8); 13C-NMR (125 MHz, DMSO-d6): δ 167.9 (C-9), 148.1 (C-4), 145.5 (C-3), 144.5 (C-7), 125.7 (C-1), 121.1 (C-6), 115.7 (C-5), 114.6 (C-8), 115.1 (C-2).
Compound 2: Yellow orange powder; C18H16O8; FAB-MS [M+1]+: m/z 361; 1H-NMR (500 MHz, DMSO-d6): δ 7.46 (1H, d, J = 15.5 Hz, H-7′), 7.05 (1H, d, J = 2.0 Hz, H-2′), 7.01 (1H, dd, J = 8.0, 2.0 Hz, H-6′), 6.76 (1H, d, J = 8.0 Hz, H-5′), 6.67 (1H, d, J = 2.0 Hz, H-2), 6.63 (1H, d, J = 8.0 Hz, H-5), 6.52 (1H, dd, J = 8.0, 1.5 Hz, H-6), 6.23 (1H, d, J = 16.0 Hz, H-8′), 5.03 (1H, dd, J = 8.5, 4.5 Hz, H-8), 2.90 (1H, dd, J = 14.0, 8.5 Hz, H-7a), 2.98 (1H, dd, J = 14.5, 4.0 Hz, H-7b); 13C-NMR (125 MHz, DMSO-d6): δ 170.8 (C-9), 165.9 (C-9′)), 148.6 (C-4′), 145.9 (C-7′), 145.6 (C-3′), 144.9 (C-3), 144.0 (C-4), 127.2 (C-1), 125.3 (C-1′), 121.6 (C-6′), 120.0 (C-6), 116.7 (C-2), 115.7 (C-5′), 115.4 (C-8′), 114.9 (C-5), 113.2 (C-2′), 72.8 (C-8), 36.1 (C-7).
Compound 3: Yellow orange powder; C16H12O6; EI-MS: m/z 300 [M]+ (100), 285 (64.0), 257 (55.0), 167 (14.0), 139 (16.0), 119 (17.0), 84 (70.0), 66 (72.0); 1H-NMR (500 MHz, DMSO-d6) and 13C-NMR (125 MHz, DMSO-d6): see Tables 1 and 2.
Table 1.
1H-NMR spectroscopy data for compounds 3–11 from S. plebeia.
| No. | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 |
|---|---|---|---|---|---|---|---|---|---|
| 2 | - | - | - | - | - | - | 5.46 (dd, 13.0, 3.0) | 5.41 (dd, 5.0, 2.5) | - |
| 3 | 6.59 (s) | 6.67 (s) | 6.89 (s) | 6.73 (s) | 6.86 (s) | 6.69 (s) | - | - | 6.86 (s) |
| 3α | - | - | - | - | - | - | 3.15 (m) | 3.16 (m) | - |
| 3β | - | - | - | - | - | - | 2.71 (dd, 17.5, 3.0) | 2.70 (m) | - |
| 4 | - | - | - | - | 10.43 (s) | - | - | - | - |
| 5 | - | - | - | - | - | - | - | - | - |
| 6 | - | 6.18 (d, 2.0) | - | - | - | - | - | - | 6.44 (s) |
| 7 | - | - | - | - | - | - | - | - | - |
| 8 | 6.23 (s) | 6.43 (d, 2.0) | 6.71 (s) | 6.97 (s) | 7.02 (s) | 6.96 (s) | 6.31 (s) | 6.31 (s) | 6.83 (s) |
| 9 | - | - | - | - | - | - | - | - | - |
| 10 | - | - | - | - | - | - | - | - | - |
| 1' | - | - | - | - | - | - | - | - | - |
| 2' | 7.85 (d, 9.0) | 7.39 (d, 2.5) | 7.42 (d, 2.0) | 7.41 (d, 2.0) | 7.95 (d, 9.0) | 7.39 (d, 2.0) | 7.32 (d, 8.5) | 6.76 (s) | 7.94 (d, 8.0) |
| 3' | 6.89 (d, 8.5) | - | - | - | 6.93 (d, 8.5) | - | 6.79 (d, 8.5) | 9.10 (s) | 6.92 (d, 8.5) |
| 4' | - | - | - | - | - | - | 9.61 (s) | 9.05 (s) | 10.53 (s) |
| 5' | 6.89 (d, 8.5) | 6.90 (d, 8.5) | 6.84 (d, 8.5) | 6.89 (d, 8.0) | 6.93 (d, 8.5) | 6.88 (d, 8.0) | 6.79 (d, 8.5) | 6.87 (s) | 6.92 (d, 8.5) |
| 6' | 7.85 (d, 9.0) | 7.42 (dd, 8.5, 2.5) | 7.45 (dd, 2.0, 8.0) | 7.44 (dd, 8.0, 2.0) | 7.95 (d, 9.0) | 7.42 (dd, 2.0, 9.0) | 7.32 (d, 8.5) | 6.76 (s) | 7.94 (d, 8.0) |
| G-1 | - | - | - | 5.13 (d, 7.5) | 5.12 (d, 14.0) | 5.01 (d, 7.5) | 4.98 (d, 7.0) | 5.04 (d, 4.0) | 5.40 (s) |
| G-2' | - | - | - | 3.17–3.72 (m) | 3.19–3.72 (m) | 3.19–3.74 (m) | - | 3.26–3.64 (m) | 3.71 (d, 11.5) |
| G-3' | - | - | - | 3.17–3.72 (m) | 3.19–3.72 (m) | 3.19–3.74 (m) | - | 3.26–3.64 (m) | 3.18–3.72 (m) |
| G-4 | - | - | - | 3.17–3.72 (m) | 3.19–3.72 (m) | 3.19–3.74 (m) | - | 3.26–3.64 (m) | 3.18–3.72 (m) |
| G-5 | - | - | - | 3.17–3.72 (m) | 3.19–3.72 (m) | 3.19–3.74 (m) | - | 3.26–3.64 (m) | 3.18–3.49 (m) |
| G-6 | - | 12.98 (s) | 13.02 (s) | 3.17–3.72 (m) | 3.19–3.72 (m) | 3.19–3.74 (m) | - | 3.26–3.64 (m) | 3.18–3.49 (m) |
| 5-OH | 12.96 (s) | - | 3.73 (s) | 13.02 (s) | 12.97 (s) | 12.76 (s) | 11.97 (s) | 11.97 (s) | 12.99 (s) |
| 6-OCH3 |
3.68 (s) |
- |
3.93 (s) |
3.76 (s) |
3.76 (s) |
- |
3.68 (s) |
3.68 (s) |
- |
| 3'-OCH3 | - | - | - | - | - | - | - |
Table 2.
13C-NMR spectroscopy data for compounds 3–11 from S. plebeia.
| No. | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 |
|---|---|---|---|---|---|---|---|---|---|
| 2 3 4 5 6 7 8 9 10 1′ 2′ 3′ 4′ 5′ 6′ G-1 G-2 G-3 G-4 G-5 G-6 6-OCH3 |
162.9 102.1 181.3 153.0 132.0 157.4 94.8 152.4 104.2 121.3 128.2 116.0 161.2 116.0 128.2 - - - - - - 59.5 |
163.9 102.8 181.6 161.5 98.8 164.2 93.8 157.3 103.7 121.5 113.3 145.7 149.7 116.0 119.0 - - - - - - - |
164.4 102.4 182.0 152.6 131.8 158.5 91.4 152.1 105.0 121.0 113.1 146.0 150.0 115.9 119.2 - - - - - - 60.0 |
164.6 102.5 182.1 152.5 132.4 156.4 94.2 152.1 105.7 121.0 113.2 145.8 151.0 115.9 119.2 100.1 73.2 77.2 69.5 76.7 60.6 60.3 |
164.6 102.6 182.3 152.4 132.5 156.4 94.3 152.1 105.7 120.9 128.6 116.0 161.0 116.0 128.6 100.2 73 69.5 77.3 76.7 60.6 60.3 |
164.3 102.4 182.2 146.6 130.4 151.3 93.2 150.1 105.8 121.3 113.3 145.8 149.0 115.9 119.0 100.9 73.2 77.3 69.6 75.8 60.6 - |
78.8 42.2 197.9 154.4 130.1 159.0 95.6 158.9 903.2 129.7 128.8 115.2 158.6 115.2 128.8 100.0 73.1 78.7 69.6 77.2 60.5 60.3 |
78.9 42.3 197.8 158.4 130.1 158.6 94.4 158.0 106.0 121.1 114.4 145.8 145.2 115.2 118.0 103.2 73.1 77.3 69.5 76.6 60.5 60.3 |
163.5 102.9 181.9 156.9 99.8 164.3 94.8 162.9 105.3 121.0 128.6 116.1 161.1 116.1 128.6 99.5 73.1 77.1 69.6 76.4 60.6 - |
| 3′-OCH3 | - | - | 56.4 | - | - | - | - | - | - |
Compound 4: Yellow powder; C15H10O6; EI-MS: m/z 286 [M]+ (100), 258 (12.0), 229 (5.0), 180 (2.0), 153 (19.0), 129 (10.0), 106 (1.0), 88 (1.5), 69 (4.0); 1H-NMR (500 MHz, DMSO-d6) and 13C-NMR (125 MHz, DMSO-d6): see Tables 1 and 2.
Compound 5: Yellow powder; C17H14O7; EI-MS: m/z 330 [M]+ (55.0), 315 (45.0), 301 (14.0), 287 (29.0), 181 (11.0), 153 (28.0), 135 (9.0), 84 (100), 66 (98.0); 1H-NMR (500 MHz, DMSO-d6) and 13C-NMR (125 MHz, DMSO-d6): see Tables 1 and 2.
Compound 6: Yellow powder; C22H22O12; FAB-MS: m/z 479 [M+1]+; 1H-NMR (500 MHz, DMSO-d6) and 13C-NMR (125 MHz, DMSO-d6): see Tables 1 and 2.
Compound 7: White yellow powder; C22H22O11; FAB-MS: m/z 463 [M+1]+; 1H-NMR (500 MHz, DMSO-d6) and 13C-NMR (125 MHz, DMSO-d6): see Tables 1 and 2.
Compound 8: Yellow powder; C21H20O12; FAB-MS: m/z 465 [M+1]+; 1H-NMR (500 MHz, DMSO-d6) and 13C-NMR (125 MHz, DMSO-d6): see Tables 1 and 2.
Compound 9: White yellow powder; C22H24O11; FAB-MS: m/z 465 [M+1]+; 1H-NMR (500 MHz, DMSO-d6) and 13C-NMR (125 MHz, DMSO-d6): see Tables 1 and 2.
Compound 10: Yellow powder; C22H24O12; FAB-MS: m/z 481 [M+1]+; 1H-NMR (500 MHz, DMSO-d6) and 13C-NMR (125 MHz, DMSO-d6): see Tables 1 and 2.
Compound 11: Yellow powder; C21H20O10; FAB-MS: m/z 433 [M+1]+; 1H-NMR (500 MHz, DMSO-d6) and 13C-NMR (125 MHz, DMSO-d6): see Tables 1 and 2.
2.4. Sample preparation and HPLC analysis
SPW was obtained from ground SP extracted in water (85 °C, 8 h), filtered, and dried using a spray dryer. SPW was cultivated in Gyeongsangbuk-do, Korea and provided by FromBio (Gyeonggi-do, Korea). SPE, SPM, SJM, SOM, SPM, and SPW were dissolved in MeOH (20 mg/mL). Phenolic acid and flavonoid standard compounds were also dissolved in MeOH (1 mg/mL). All samples were sonicated for 20 min and filtered through a syringe filter (0.45-μm) prior to analyses. The chromatographic separation of individual components was conducted using an YMC Pro C18 column (250 × 4.6 mm, 5μm). The mobile phase comprised a mixture of 0.5% acetic acid in water (0.5:95.5, v/v) (solvent A) and ACN (solvent B). Gradient elution started with 95% of solvent A and decreased to 75% after 20 min. Solvent A was decreased to 50% at 45 min and further decreased to 10% at 55 min. It was then increased to 65% at 65 min and maintained until 70 min. The injection volume was 10 μL and the flow rate was 1.0 mL/min. The UV detection wavelength was 280 nm.
2.5. Calibration curves
Standard compounds were serially diluted to prepare different concentrations (0.1–1.0 mg/mL). A calibration curve for each standard was constructed by plotting concentration (x, μg/mL) versus peak area (y). Linearity was assessed from the correlation coefficient value (r2).
3. Results and discussion
Open column chromatography using silica gel was performed and a total of 2 phenolic acids and 9 flavonoids were isolated from the EtOAc and n-BuOH fractions of SPE. Flavonoids in SP have been used as marker compounds to evaluate its medicinal value and are mainly responsible for its bioactivity. We isolated two classes of phenolic acids and flavonoids (Figure 1). NMR and MS spectroscopy elucidated the structures of the isolated compounds and the results are shown in Table 1 for 1H-NMR and Table 2 for 13C-NMR data. The HPLC-UV chromatogram of standard compounds are shown in Figure 2. Quantitative analyses were performed in four different Salvia species and separation of individual components was achieved using HPLC-UV analysis (Figures 2B-2G).
Figure 2.
HPLC chromatograms of compounds 1–11 (A), SPE (B), SPW (C), SPM (D), SJM (E), SSS (F), and SOM (G) caffeic acid (1), rosmarinic acid (2), hispidulin (3), luteolin (4), jaceosidin (5), nepitrin (6), homoplantaginin (7), 6-hydroxyluteolin 7-O-glucoside (8), 6-methoxynaringenin 7-O-glucoside (9), naasanone (10), and cosmosiin (11).
Compounds 1 and 2 were identified as caffeic acid and rosmarinic acid, respectively, based on previous literature (Kil et al., 2020). Caffeic acid (1) is a hydroxycinnamic derivative present in many food sources. It acts as a carcinogenic inhibitor and possesses antioxidant and antibacterial activity (Magnani et al., 2014). Rosmarinic acid (2) possesses platelet anti-aggregation, hepatoprotection, nitric oxide inhibition, anti-oxidation and vaso-relaxation (Nugroho et al., 2012).
Structures 3–8 and 11 were identified as flavone compounds such as hispidulin (3), luteolin (4), jaceosidin (5), nepitrin (6), homoplantaginin (7), 6-hydroxyluteolin 7-O-glucoside (8) and cosmosiin (11) by comparing their MS, 1H-, and 13C-NMR data with previous studies (Lee et al., 2010, 2021; Ren et al., 2014; Kil et al., 2020; Cuong et al., 2019; Yuan et al., 2016). Hispidulin (3) is a naturally occurring flavone with anti-fungal, antioxidant, anti-inflammatory, anxiolytic, and anticonvulsive properties (Lin et al., 2010; Kavvadias et al., 2004). A previous study reported that luteolin (4) could be used to treat influenza A virus, H1N1, due to its enzymatic inhibition of H1N1 neuraminidase (Bang et al., 2016). Jaceosidin (5) exhibits various pharmacological activities including antibacterial, anti-allergic, anti-inflammatory, and anti-cancer (Nageen et al., 2021). Nepitrin (6) has significant anti-inflammatory, anti-pyretic, and anti-arthritic activity (Agarwal, 1982). Homoplantaginin (7) exhibits anti-inflammatory, antioxidant, and anti-influenza activities (Bang et al., 2016). 6-Hydroxyluteolin 7-O-glucoside (8) exerts anti-inflammatory effects (Williams et al., 1999) while cosmosiin (11) exhibited anti-cancer and anti-diabetes activities (Rao et al., 2011).
The 1H- and 13C-NMR spectra of compounds 9 and 10 depicted flavanone structures and were elucidated to be 6-methoxynaringenin 7-O-glucoside (9) and naasanone (= 5,7,3′,4′-tetrahydroxy-6-methoxyflavanone 7-O-glucoside) (10), respectively, based on the previous studies (Ren et al., 2014; Lee et al., 2010). Naasanone (10) is a newly isolated compound from S. plebeia.
The quantitative analyses of phenolic acids and flavonoids from S. plebeia showed their levels varied depending on the type of extract used. Our results showed that the main flavonoid in SPE was 6-hydroxyluteolin 7-O-glucoside (8) which exhibited the highest peak (100.63 mg/g) in the HPLC chromatogram (Figure 2B). High levels of nepitrin (6) and homoplantaginin (7) were also detected at 59.15 and 27.83 mg/g, respectively (Table 3). These were previously considered to be the major flavone compounds in SPE (Lee et al., 2018).
Table 3.
Contents of compounds 1–11 in different Salvia species.
| Compound | Content (mg/g) |
|||||
|---|---|---|---|---|---|---|
| SPE | SPW | SPM | SJM | SSM | SOM | |
| 1 | 0.56 ± 0.05 | 0.61 ± 0.02 | 0.26 ± 0.06 | 0.18 ± 0.02 | 0.27 ± 0.06 | 0.18 ± 0.00 |
| 2 | 47.70 ± 0.19 | 18.10 ± 0.01 | 48.22 ± 0.61 | 2.13 ± 0.04 | 1.67 ± 0.03 | 1.58 ± 0.03 |
| 3 | 0.56 ± 0.02 | 0.75 ± 0.01 | 0.29 ± 0.03 | 0.15 ± 0.00 | 0.08 ± 0.00 | 0.03 ± 0.01 |
| 4 | 1.18 ± 0.01 | 7.58 ± 0.19 | 0.63 ± 0.12 | 1.34 ± 0.08 | 0.12 ± 0.01 | 0.22 ± 0.01 |
| 5 | 0.03 ± 0.01 | 2.37 ± 0.05 | 0.58 ± 0.06 | - | 0.24 ± 0.01 | 0.04 ± 0.01 |
| 6 | 59.15 ± 0.65 | 10.64 ± 0.10 | 30.02 ± 0.69 | 0.89 ± 0.19 | 0.39 ± 0.00 | 1.87 ± 0.02 |
| 7 | 27.83 ± 0.26 | 2.29 ± 0.05 | 28.10 ± 0.20 | - | - | - |
| 8 | 100.63 ± 0.29 | 3.66 ± 0.04 | 99.26 ± 0.92 | - | 0.62 ± 0.00 | 1.04 ± 0.02 |
| 9 | 10.51 ± 0.18 | 0.39 ± 0.02 | 0.98 ± 0.08 | - | 0.25 ± 0.00 | 0.27 ± 0.02 |
| 10 | 0.58 ± 0.09 | 0.12 ± 0.02 | 2.87 ± 0.33 | - | 0.03 ± 0.03 | 0.10 ± 0.01 |
| 11 | 4.61 ± 0.01 | 2.16 ± 0.12 | 5.14 ± 0.22 | 0.31 ± 0.02 | 1.16 ± 0.03 | 0.06 ± 0.00 |
The most abundant phenolic acid was rosmarinic acid (2) having contents of 47.70 mg/g and 18.10 mg/g in SPE and SPW, respectively. As presented in the HPLC chromatogram (Figure 2C), peak number 2 was the highest in SPW indicating that the major constituent was rosmarinic acid (2). SPE showed an overall higher content of major flavonoids. However, while SPW contained relatively high rosmarinic acid (2) levels, they were not as high as SPE. These findings agreed with a recent study where water extract contained large amounts of rosmarinic acid (2) (Kil et al., 2020). The higher content of rosmarinic acid (2) in S. plebeia suggests it as a potential functional ingredient in cosmetics (Lee et al., 2018). Additionally, the contents of caffeic acid (1), luteolin (4), and jaceosidin (5) were higher in SPW suggesting the use of water as a solvent for extraction will obtain a higher yield of these compounds (Figures 2B and 2C).
In a previous report, the content of nepitrin (6) and 6-hydroxyluteolin 7-O-glucoside (8) in the MeOH extract (27.75 and 17.96 mg/g, respectively) was much lower to that of EtOH extract found in our study (Nugroho et al., 2012). Likewise, the compounds hispidulin (3), nepitrin (6), and homoplantaginin (7) had higher concentration in SPE (Jin et al., 2011).
The major flavanone previously detected in SP was naasanone (10) with a content of 938.3 mg/100 g DW and 6-methoxynaringenin 7-O-glucoside (9) was not detected (Lee et al., 2018). In contrast, the glycosidic flavanone 6-methoxynaringenin 7-O-glucoside (9) showed the highest content in the EtOH extract (10.51 mg/g) and the lowest in the DW extract (0.39 mg/g). These differences could be attributable to several factors such as agro-ecological variations in plant growth, extraction procedures, and analytical quantification methods (Lee et al., 2010; Bang et al., 2016; Kim et al., 2016). Although they exhibited significant pharmacological activities, flavanone and other sub-classes of flavonoids are rarely reported (Cabrera et al., 2007). Therefore, further studies are required regarding the isolation of flavanones from S. plebeia so they can be utilized for biological assays.
Phenolic acid and flavonoid contents in SJM, SSM, and SOM were also quantified. Among the four Salvia species, the SPM extract contained the highest content of phenolic acids and flavonoids (Table 3). Rosmarinic acid (2) was the major phenolic acid in SJM (2.13 mg/g), SSM (1.67 mg/g), and SOM (1.58 mg/g) with SJM having the highest content. As shown in Figures 2D-2G, peak 2 was the highest in all HPLC chromatograms of three Salvia species indicating that rosmarinic acid (2) was the major constituent. The major flavonoid was 6-hydroxyluteolin 7-O-glucoside (8) in the SPM extract (99.26 mg/g). This extract also contained slightly higher amounts of rosmarinic acid (2), homoplantaginin (7), and cosmosiin (11), when compared with SPE.
Alcoholic extracts from S. officinalis and several Salvia species are rich in phenolic compounds, particularly rosmarinic acid (2) (Ghorbani and Esmaeilizadeh, 2017). The flavonoid nepitrin (6) was highest in SOM (1.87 mg/g) whereas luteolin was highest in SJM (1.34 mg/g). This suggests that SOM contained a higher amount of these two marker compounds and could be utilized for its bioactivity. In SJM, only major flavonoids and phenolic acids such as caffeic acid (1), rosmarinic acid (2), hispidulin (3), luteolin (4), and cosmosiin (11) were detected. Homoplantaginin (7) was not detected in the three Salvia species suggesting barely detectable levels. SSM contained the highest amount of cosmosiin (11) at 1.16 mg/g.
Several Salvia species have been intensively studied as they possess a wide range of bioactive components, with their antioxidant properties primarily attributed to rosmarinic acid (2) (Fatma et al., 2017). Among the three Salvia species studied here, S. officinalis was the best documented. It is native to the Middle East and Mediterranean areas and has been used as a folk medicine to treat different types of health problems. The plant contains a plethora of bioactive constituents such as waxes, fatty acids, carbohydrates, alkaloids, phenolic compounds (e.g., flavonoids, coumarins, and tannins), steroids, poly acetylenes, and terpenoids (e.g., monoterpenoids, sesquiterpenoids, diterpenoids, and triterpenoids) (Ghorbani and Esmaeilizadeh, 2017). Pharmacological findings include antioxidant, anti-microbial, anti-cancer, anti-nociceptive, anti-inflammatory, anti-mutagenic, anti-dementia, hypolipidemic, and hypoglycemic effects (Garcia et al., 2016).
Overall, our findings suggest that the Salvia species studied here are good sources of rosmarinic acid (2). SOM had higher amounts of biomarker compounds as compared to the other Salvia species. However, SJM had a higher content of rosmarinic acid (2) but also had lower amounts of other flavonoids.
4. Conclusions
In total, 11 compounds were isolated and characterized from SPE. The majority were flavonoids which are the major phytochemical constituents of this plant. These compounds are reportedly responsible for its several bioactivities. The compound 6-hydroxyluteolin 7-O-glucoside (8) had the highest content in the SPE and SPM, whereas rosmarinic acid (2) was highest in SPW. The major flavonoids in SPE were similar to SPM. Furthermore, SPE and SPM could be a viable source of abundant flavonoids. Rosmarinic acid (2) was the major compound found in SJM, SSM, and SOM and could be a potential marker compound to evaluate the medicinal value of this plant.
Declarations
Author contribution statement
Leo Adrianne Paje: Conceived and designed the experiments; Performed the experiments; Contributed reagents, materials, analysis tools or data.
Jungwon Choi, Hak-Dong Lee, Juree Kim, A Ram Yu, Min-Jung Bae: Performed the experiments.
Paul John L. Geraldino: Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data; Wrote the paper.
Sanghyun Lee: Conceived and designed the experiments; Analyzed and interpreted the data; Wrote the paper.
Funding statement
This work was supported by the Ministry of Trade, Industry and Energy (MOTIE) and the Korea Institute for Advancement of Technology (KIAT) through the National Innovation Cluster R&D program (P0006892 Crop Growth Information Quantification System and Commercialization of Big Data Services).
Data availability statement
Data will be made available on request.
Declaration of interests statement
The authors declare no conflict of interest.
Additional information
No additional information is available for this paper.
References
- Agarwal O.P. The anti-inflammatory action of nepitrin, a flavonoid. Agents Actions. 1982;12(3):298–302. doi: 10.1007/BF01965393. [DOI] [PubMed] [Google Scholar]
- Bang S., Quy Ha T.K., Lee C., Li W., Oh W.K., Shim S.H. Antiviral activities of compounds from aerial parts of Salvia plebeia R. Br. J. Ethnopharmacol. 2016;192:398–405. doi: 10.1016/j.jep.2016.09.030. [DOI] [PubMed] [Google Scholar]
- Cabrera M., Simoens M., Falchi G., Lavaggi M.L., Piro O.E., Castellano E.E., Sagrera G. Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure: activity relationships. Bioorg. Med. Chem. 2007;15(10):3356–3367. doi: 10.1016/j.bmc.2007.03.031. [DOI] [PubMed] [Google Scholar]
- Choi J.K., Oh H.M., Park J.H., Choi J.H., Sa K.H., Kang Y.M., Park P.H., Shin T.Y., Rho M.C., Kim S.H. Salvia plebeia extract inhibits the inflammatory response in human rheumatoid synovial fibroblasts and a murine model of arthritis. Phytomedicine. 2015;22(3):415–422. doi: 10.1016/j.phymed.2015.01.007. [DOI] [PubMed] [Google Scholar]
- Cuong D.T.D., Dat H.T., Duan N.T., Thuong P.D., Phat N.T., Tri M.D., Van Son D., Hoa N.T., Tuyen P.N.K., Phung N.K.P. Isolation and characterization of six flavonoids from the leaves of Sterculia foetida Linn. Viet. J. Chem. 2019;57(4):438–442. [Google Scholar]
- Fatma Ebru K., Ayse A., Caglar K. Extraction and HPLC analysis of sage (Salvia officinalis) plant. Nat. Prod. Chem. Res. 2017;5(8):298. [Google Scholar]
- Garcia C.S.C., Menti C., Lambert A.P.F. Pharmacological perspectives from Brazilian Salvia officinalis (Lamiaceae): antioxidant, and antitumor in mammalian cells. An. Acad. Bras. Cienc. 2016;88(1):281–292. doi: 10.1590/0001-3765201520150344. [DOI] [PubMed] [Google Scholar]
- Ghorbani A., Esmaeilizadeh M. Pharmacological properties of Salvia officinalis and its components. J. Trad. Comp. Med. 2017;7(4):433–440. doi: 10.1016/j.jtcme.2016.12.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jin X.F., Qian J., Lu Y.H. The role of hepatoprotective effect of a flavonoid-rich extract of Salvia plebeia R. Br. on carbon tetrachloride-induced acute hepatic injury in mice. J. Med. Plants Res. 2011;5(9):1558–1563. [Google Scholar]
- Kavvadias D., Sand P., Youdim K.A., Qaiser M.Z., Rice-Evans C., Baur R., Sigel E., Rausch W.D., Riederer P., Schreier P. The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects. Br. J. Pharmacol. 2004;142(5):811–820. doi: 10.1038/sj.bjp.0705828. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kil H.W., Rho T., Young J.S., Yu A., Yoon K.D. Isolation of phytochemicals from Salvia plebeia using countercurrent chromatography coupled with reversed-phase HPLC. Nat. Prod. Sci. 2020;26(3):236–243. [Google Scholar]
- Kim M.H., Jung K., Nam K.H., Jang H.J., Lee S.W., Kim Y., Park C.S., Lee T.H., Park J.H., Choi J.H., Rho M.C., Oh H.M. Salvia plebeia R. Br. inhibits signal transduction of IL-6 and prevents ovariectomy-induced bone loss by suppressing osteoclastogenesis. Arch Pharm. Res. (Seoul) 2016;39(12):1671–1681. doi: 10.1007/s12272-016-0810-0. [DOI] [PubMed] [Google Scholar]
- Lee G.T., Duan C.H., Lee J.N., Lee K.S., Hong J.T., Lee K.K. Phytochemical constituents from Salvia plebeia. Nat. Prod. Sci. 2010;16(4):207–210. [Google Scholar]
- Lee H.-D., Paje L.A., Choi J., Kim J., Yu A.R., Bae M.-J., Lee S. HPLC/DAD method validation of 6-hydroxyluyeolin 7-O-glucoside analysis from Salvia plebeia. Korean J. Pharmacogn. 2021;52(3):186–191. [Google Scholar]
- Lee S.H., Kim H.W., Lee M.K., Kim Y.J., Asamenew G., Cha Y.S., Kim J.B. Phenolic profiling and quantitative determination of common sage (Salvia plebeia R. Br.) by UPLC-DAD-QTOF/MS. Eur. Food Res. Technol. 2018;244:1637–1646. [Google Scholar]
- Liang Y.Y., Wan X.H., Niu F.J., Xie S.M., Guo H., Yang Y.Y., Guo L.Y., Zhou C.Z. Salvia plebeia R. Br.: an overview about its traditional uses, chemical constituents, pharmacology and modern applications. Biomed. Pharmacother. 2020;121:109589. doi: 10.1016/j.biopha.2019.109589. [DOI] [PubMed] [Google Scholar]
- Lin Y.C., Hung C.M., Tsai J.C., Lee J.C., Chen Y.L., Wei C.W., Kao J.Y., Way T.D. Hispidulin potently inhibits human glioblastoma multiforme cells through activation of AMP-activated protein kinase (AMPK) J. Agric. Food Chem. 2010;58(17):9511–9517. doi: 10.1021/jf1019533. [DOI] [PubMed] [Google Scholar]
- Lu Y., Foo L.Y. Polyphenolics of Salvia - a review. Phytochemistry. 2002;59(2):117–140. doi: 10.1016/s0031-9422(01)00415-0. [DOI] [PubMed] [Google Scholar]
- Magnani C., Isaac V.L.B., Marcos C., Salgado H. Caffeic acid: a review of its potential use in medications and cosmetics. Anal. Methods. 2014;6(10):3203. [Google Scholar]
- Nageen B., Rasul A., Hussain G., Shah M.A., Anwar H., Hussain S.M., Uddin M.S., Sarfraz I., Riaz A., Selamoglu Z. Jaceosidin: a natural flavone with versatile pharmacological and biological activities. Curr. Pharmaceut. Des. 2021;27(4):456–466. doi: 10.2174/1381612826666200429095101. [DOI] [PubMed] [Google Scholar]
- Nugroho A., Kim M.H., Choi J., Baek N.I., Park H.J. In vivo sedative and gastroprotective activities of Salvia plebeia extract and its composition of polyphenols. Arch Pharm. Res. (Seoul) 2012;35(8):1403–1411. doi: 10.1007/s12272-012-0810-7. [DOI] [PubMed] [Google Scholar]
- Rao Y.K., Lee M.J., Chen K., Lee Y.C., Wu W.S., Tzeng Y.M. Insulin-mimetic action of rhoifolin and cosmosiin isolated from Citrus grandis (L.) Osbeck leaves: enhanced adiponectin secretion and insulin receptor phosphorylation in 3T3-L1 cells. Evid. Based Compl. Alternat. Med. 2011;2011:624375. doi: 10.1093/ecam/nep204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ren D.B., Qin Y.H., Yun Y.H., Lu H.M., Chen X.Q., Liang Y.Z. Separation of nine compounds from Salvia plebeia R.Br. using two-step high-speed counter-current chromatography with different elution modes. J. Separ. Sci. 2014;37(16):2118–2125. doi: 10.1002/jssc.201400293. [DOI] [PubMed] [Google Scholar]
- Wang J.F., Yan W.W., Xu J.X. Research progress in chemical constituents and pharmacological effects of Salvia plebeia R. Br. J. Hunan Univ. Chin. Med. 2018;38:482–485. [Google Scholar]
- Williams C.A., Harborne J.B., Geiger H., Hoult J.R. The flavonoids of Tanacetum parthenium and T. vulgare and their anti-inflammatory properties. Phytochemistry. 1999;51(3):417–423. doi: 10.1016/s0031-9422(99)00021-7. [DOI] [PubMed] [Google Scholar]
- Yuan H., Lu X., Ma Q., Li D., Xu G., Piao G. Flavonoids from Artemisia sacrorum Ledeb. and their cytotoxic activities against human cancer cell lines. Exp. Ther. Med. 2016;12(3):1873–1878. doi: 10.3892/etm.2016.3556. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data will be made available on request.